« Previous
Next »
The Journal of Pediatrics
Volume 148, Issue 6
, Pages 713-714
, June 2006
Treatment to prevent patency of the ductus arteriosus: Beneficial or harmful?
References
- Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants . N Engl J Med . 2001;344:1966–1972
- Indomethacin prophylaxis, patent ductus arteriosus and the risk of bronchopulmonary dysplasia . J Pediatr . 2006;148:730–734
- . Risk factors for chronic lung disease in the surfactant era (a North Carolina population-based study of very low birth weight infants) . Pediatrics . 1999;104:1345–1350
- Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants . J Pediatr . 2005;147:786–790
- . Inhibition of COX-2 aggravates neutrophil migration and pneumocyte apoptosis in surfactant-depleted rat lungs . Pediatr Res . 2006;59:412–417
- . Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome . J Pediatr . 2001;138:205–211
- . Prophylactic indomethacin (factors determining permanent ductus arteriosus closure) . J Pediatr . 2000;136:330–337
-
.
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants
.
Cochrane Database Syst Rev
. 2003;
CD003745
- . The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials . Semin Neonatol . 2001;6:63–73
-
.
Retrolental fibroplasia
(a modern parable)
. New York: Grune & Stratton, Inc; 1980;
PII: S0022-3476(06)00199-5
doi: 10.1016/j.jpeds.2006.03.015
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Pediatrics
Volume 148, Issue 6
, Pages 713-714
, June 2006
